| Description | "Grisnilimab (WT1), an IgG2a monoclonal antibody targeting CD7, acts as a tumor suppressor in the pathogenesis of Wilms' tumor. It modulates the transcription of various genes and may be involved in post-transcriptional RNA processing [1]." |
| Synonyms | WT1 |
| molecular weight | N/A |
| CAS | 2367001-70-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |